Provisional Consent to the Distribution of New Medicines

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Inza 250
Active Ingredient:	Naproxen 250mg
Dosage Form:	Tablet
New Zealand Sponsor:	Viatris Limited
Manufacturer:	Alphapharm Pty Limited, Brisbane, Australia
Note: This consent is given subject to the following condition: The medicine may only be marketed or distributed when no other naproxen medicine with consent under section 20 of the Medicines Act 1981 is available in the New Zealand market, or to meet Pharmac supply obligations.
Note: This consent is valid for two years from the date of publication of this notice.

*Product:*	Inza 500
Active Ingredient:	Naproxen 500mg
Dosage Form:	Tablet
New Zealand Sponsor:	Viatris Limited
Manufacturer:	Alphapharm Pty Limited, Brisbane, Australia
Note: This consent is given subject to the following condition: The medicine may only be marketed or distributed when no other naproxen medicine with consent under section 20 of the Medicines Act 1981 is available in the New Zealand market, or to meet Pharmac supply obligations.
Note: This consent is valid for two years from the date of publication of this notice.

Dated this 5th day of May 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11th day of September 2013).

Tags

Notice Number

Schedule